CoChat

Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake Inhibitors: A Clinical Investigation

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Objective Many authors have reported discontinuation symptoms associated with selective serotonin reuptake inhibitors (SSRIs). The aim of this study was to investigate the incidence and characteristics of the discontinuation syndrome in patients who stopped treatment with the SSRIs paroxetine and fluoxetine under the usual conditions of clinical practice, and to identify clinical predictors of the syndrome. Methods Ninety-seven outpatients who received an initial diagnosis of dysthymic disorder, who responded to >or=8 weeks treatment with paroxetine (n = 52) or fluoxetine (n = 45), and who discontinued the SSRI according to their psychiatrist's instructions were included. They were assessed at the time of discontinuation using a semi-structured interview for clinical and treatment characteristics, the Hamilton Depression Rating Scale (HAM-D) and the Montgomery-Asberg Depression Rating Scale (MADRS). Patients were then assessed 4 weeks later using a checklist for discontinuation symptoms, a semi-structured interview for discontinuation symptom characteristics, and the HAM-D and the MADRS. Results A discontinuation syndrome was found in 26 patients (26.8% of our sample); of this group, 22 patients (84.6%) had received paroxetine, and 4 patients (15.4%) had received fluoxetine. The mean time at onset of symptoms was 2 days after drug discontinuation and the mean duration was 5 days. The statistical comparison between the groups with and without a discontinuation syndrome found t…

Overview

Integrity signals

Registry

Crossref · 10.2165/00023210-200216040-00006

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Research works printed but not linked: 10

  1. Diamond, 1989, Psychopharmacol Bull, 25, 209
  2. Halle, 1993, J Psychiatry Neurosci, 18, 49
  3. Stoukides, 1991, Am J Psychiatry, 148, 1263
  4. Black, 1993, J Clin Psychiatry, 54, 146
  5. Einbinder, 1995, Am J Psychiatry, 152, 1235
  6. Frost, 1995, Am J Psychiatry, 152, 810
  7. Kasantikul, 1995, J Med Assoc Thai, 78, 53
  8. Pyke, 1995, Am J Psychiatry, 152, 149
  9. Berlin, 1996, J Clin Psychiatry, 57, 93
  10. Black, 2000, J Psychiatry Neurosci, 25, 255

Cited by

See all 86

Metadata

Authors
Bogetto, F., Bellino, S., Revello, R. B., & Patria, L.
Affiliations
University of Turin (IT)
Corresponding author
Bellino, Silvio
Venue
CNS Drugs
Published
2002
Volume
16
Issue
4
Pages
273-283
ISSN
1172-7047 (ISSN-L)
OpenAlex
W21422233
Cited by
80
References
50
Citations by year
2026: 2 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 2
FWCI
1.82
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
discontinuation syndrome, selective serotonin reuptake inhibitors, dysthymia, paroxetine, fluoxetine, antidepressant discontinuation, age at onset of depression, sex differences
MeSH terms
Adolescent, Adult, Aged, Female, Fluoxetine, Humans, Interview, Psychological, Male, Middle Aged, Psychiatric Status Rating Scales, Substance Withdrawal Syndrome, Time Factors, Selective Serotonin Reuptake Inhibitors, Paroxetine, Antidepressive Agents, Second-Generation, Dysthymic Disorder

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake Inhibitors: A Clinical Investigation. https://app.cochat.ai/papers/10.2165/00023210-200216040-00006
The paper
Bogetto, F., Bellino, S., Revello, R. B., & Patria, L. (2002). Discontinuation Syndrome in Dysthymic Patients Treated with Selective Serotonin Reuptake Inhibitors: A Clinical Investigation. CNS Drugs. https://doi.org/10.2165/00023210-200216040-00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.